Literature DB >> 28573390

Comments on Morelli et al.: Extracorporeal carbon dioxide removal (ECCO2R) in patients with acute respiratory failure.

Jérôme Allardet-Servent1, Matthias Castanier2, Thomas Signouret2, Jean-Marie Seghboyan2, Andrea Morelli3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28573390     DOI： 10.1007/s00134-017-4822-0

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

Review 1.  Extracorporeal carbon dioxide removal (ECCO2R) in patients with acute respiratory failure.

Authors:  Andrea Morelli; Lorenzo Del Sorbo; Antonio Pesenti; V Marco Ranieri; Eddy Fan
Journal:  Intensive Care Med       Date:  2017-01-28       Impact factor: 17.440

2.  Partial extracorporeal carbon dioxide removal using a standard continuous renal replacement therapy device: a preliminary study.

Authors:  Jean-Marie Quintard; Olivier Barbot; Florence Thevenot; Olivier de Matteis; Laurent Benayoun; Frank Leibinger
Journal:  ASAIO J       Date:  2014 Sep-Oct       Impact factor: 2.872

3.  Tidal volume lower than 6 ml/kg enhances lung protection: role of extracorporeal carbon dioxide removal.

Authors:  Pier Paolo Terragni; Lorenzo Del Sorbo; Luciana Mascia; Rosario Urbino; Erica L Martin; Alberto Birocco; Chiara Faggiano; Michael Quintel; Luciano Gattinoni; V Marco Ranieri
Journal:  Anesthesiology       Date:  2009-10       Impact factor: 7.892

4.  Low-flow CO₂ removal integrated into a renal-replacement circuit can reduce acidosis and decrease vasopressor requirements.

Authors:  Christian Forster; Jens Schriewer; Stefan John; Kai-Uwe Eckardt; Carsten Willam
Journal:  Crit Care       Date:  2013-07-24       Impact factor: 9.097

5.  Safety and Efficacy of Combined Extracorporeal CO2 Removal and Renal Replacement Therapy in Patients With Acute Respiratory Distress Syndrome and Acute Kidney Injury: The Pulmonary and Renal Support in Acute Respiratory Distress Syndrome Study.

Authors:  Jérôme Allardet-Servent; Matthias Castanier; Thomas Signouret; Rettinavelou Soundaravelou; Anne Lepidi; Jean-Marie Seghboyan
Journal:  Crit Care Med       Date:  2015-12       Impact factor: 7.598
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.